Fall 2022 Symposium
Engineering the Brain for Discovery and Clinical Applications
Organizers: Mo Khalil, Steve Ramirez, and Ben Wolozin
Genetic, optical, and engineering technologies increasingly allow us to observe and control the function of nerve cells. These approaches are being used to explore the brain mechanisms underlying behavior, neuroglial function, and disease. Optogenetics, synthetic biology, stem cell technology, and antisense nucleotides have enabled the creation of new bio-engineered tools to explore brain function and treat neurologic disease, while engineered systems–such as transcranial current stimulation, high speed MRI, and neural machine interfaces–provide increasingly powerful scientific tools. These approaches are being used to regulate behavior, test for and treat psychiatric and neurological disorders, and overcome nerve injury. Join us for a symposium in which we showcase the state-of-the-art research being conducted at BU and around the world. Join your colleagues in brainstorming for the next 10 years of brain engineering research.
Engineering the Brain for Discovery and Clinical Applications will be held in the Eichenbaum Colloquium Room at the Rajen Kilachand Center for Integrated Life Sciences and Engineering, located at 610 Commonwealth Avenue in Boston. Talks will be broadcast online; a link will be made available closer to the event.
Join us in-person or online!
Registered for in-person attendance but can’t make it? Join us online: http://bu.edu/csn/symposium_live
Symposium Schedule
MONDAY, OCTOBER 3 |
|
9:00 AM |
Breakfast |
9:45 AM |
Welcome: Michael Hasselmo | Boston University |
9:55 AM |
Opening remarks: Ben Wolozin and Mo Khalil | Boston University |
10:10 AM |
Anna Devor | Boston University
“Understanding the brain’s spontaneous activity with neurophotonics” |
10:50 AM |
Coffee |
11:10 AM |
Chandramouli Chandrasekaran | Boston University
“Leveraging nonlinear dimensionality reduction, graph clustering, and weighted nearest neighbors to identify candidate cell types in neural circuits” |
11:50 AM |
Christina Kim | University of California, Davis
“Linking function to molecules: New approaches for labeling activated circuits” |
12:30 PM |
Lunch |
1:30 PM |
Jason Shepherd | University of Utah
“Intercellular signaling by endogenous capsid-forming proteins – a new paradigm for gene delivery” |
2:10 PM |
Mo Khalil | Boston University
“Learning to program new cellular functions” |
2:50 PM |
Coffee |
3:10 PM |
Canan Dağdeviren | MIT
“Minimally-invasive Neural Drug Delivery System (MiNDS)” |
3:50 PM |
Robert Reinhart | Boston University
“Personalized neuromodulation: Aligning neural rhythms to improve human cognition” |
4:30 PM |
Reception |
TUESDAY, OCTOBER 4 |
|
8:45 AM |
Breakfast |
9:30 AM |
Aleena Garner | Harvard University
“A cortical circuit for audio-visual predictions” |
10:10 AM |
Laura Lewis | Boston University
“Imaging the sleeping human brain” |
10:50 AM |
Coffee |
11:10 AM |
Marom Bikson | City University of New York
“Neurovascular-modulation and how a wearable brain stimulation might treat brain disorders from age-related cognitive decline to long-COVID” |
11:50 AM |
Ben Wolozin | Boston University
“Engineering iPSCs to model brain disease and develop therapies” |
12:30 PM |
Lunch |
1:30 PM |
Kevin Guckian | Biogen
“Oligonucleotide drug discovery in the CNS” |
2:10 PM |
Closing remarks: Michael Hasselmo, Ben Wolozin,
and Mo Khalil |